Late gadolinium enhancement in pulmonary hypertension predicts clinical events
Siva Soma(Allegheny General Hospital), Robert W Biederman(Allegheny Health Network), Vikas Rathi(Bon Secours Heart & Vascular Institute), George Sokos(Allegheny General Hospital), Raymond L. Benza(Triangle), Vishal Goyal(Chandigarh University), Mark Doyle(Allegheny General Hospital), Diane A Vido(Allegheny General Hospital), Srinivas Murali(Allegheny General Hospital)
Cited by 1
Related Papers
Predicting Survival in Pulmonary Arterial Hypertension
|Circulation|2010|1.5k
Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
|Journal of the American College of Cardiology|2010|558
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis
|Journal of the American College of Cardiology|2016|540
Clinical risk factors for portopulmonary hypertension†
|Hepatology|2008|286
Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease
|American Journal of Respiratory and Critical Care Medicine|2009|232